407 related articles for article (PubMed ID: 19500993)
1. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
[TBL] [Abstract][Full Text] [Related]
2. Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Bhatia G; Srivastava AK
Bioorg Med Chem Lett; 2009 Nov; 19(22):6447-51. PubMed ID: 19811915
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
Kumar A; Ahmad P; Maurya RA; Singh AB; Srivastava AK
Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
[TBL] [Abstract][Full Text] [Related]
5. Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
Chaturvedi D; Ray S; Srivastava AK; Chander R
Bioorg Med Chem; 2008 Mar; 16(5):2489-98. PubMed ID: 18083521
[TBL] [Abstract][Full Text] [Related]
6. Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents.
Kumar A; Pathak SR; Ahmad P; Ray S; Tewari P; Srivastava AK
Bioorg Med Chem Lett; 2006 May; 16(10):2719-23. PubMed ID: 16500101
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Shi GQ; Dropinski JF; McKeever BM; Xu S; Becker JW; Berger JP; MacNaul KL; Elbrecht A; Zhou G; Doebber TW; Wang P; Chao YS; Forrest M; Heck JV; Moller DE; Jones AB
J Med Chem; 2005 Jun; 48(13):4457-68. PubMed ID: 15974597
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity.
Papi Reddy K; Singh AB; Puri A; Srivastava AK; Narender T
Bioorg Med Chem Lett; 2009 Aug; 19(15):4463-6. PubMed ID: 19515563
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents.
Kumar A; Sharma S; Tripathi VD; Maurya RA; Srivastava SP; Bhatia G; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2010 Jun; 18(11):4138-48. PubMed ID: 20471838
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
11. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
Goel A; Agarwal N; Singh FV; Sharon A; Tiwari P; Dixit M; Pratap R; Srivastava AK; Maulik PR; Ram VJ
Bioorg Med Chem Lett; 2004 Mar; 14(5):1089-92. PubMed ID: 14980641
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK
Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.
Ye YL; Zhou Z; Zou HJ; Shen Y; Xu TF; Tang J; Yin HZ; Chen ML; Leng Y; Shen JH
Bioorg Med Chem; 2009 Aug; 17(15):5722-32. PubMed ID: 19574056
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
[TBL] [Abstract][Full Text] [Related]
16. 5,6-Diarylanthranilo-1,3-dinitriles as a new class of antihyperglycemic agents.
Singh FV; Parihar A; Chaurasia S; Singh AB; Singh SP; Tamrakar AK; Srivastava AK; Goel A
Bioorg Med Chem Lett; 2009 Apr; 19(8):2158-61. PubMed ID: 19303291
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
Singh FV; Chaurasia S; Joshi MD; Srivastava AK; Goel A
Bioorg Med Chem Lett; 2007 May; 17(9):2425-9. PubMed ID: 17336063
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
[TBL] [Abstract][Full Text] [Related]
19. Flavone-based novel antidiabetic and antidyslipidemic agents.
Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R
J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508
[TBL] [Abstract][Full Text] [Related]
20. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
Cobb JE; Blanchard SG; Boswell EG; Brown KK; Charifson PS; Cooper JP; Collins JL; Dezube M; Henke BR; Hull-Ryde EA; Lake DH; Lenhard JM; Oliver W; Oplinger J; Pentti M; Parks DJ; Plunket KD; Tong WQ
J Med Chem; 1998 Dec; 41(25):5055-69. PubMed ID: 9836622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
